Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer

Mayo Clinic · NCT07527143

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 45+ · Women only
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
25
US sites recruiting
1
Study start
June 10, 2026
Record last updated
July 9, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This study evaluates how women feel about using DNA from a vaginal fluid collection for early detection of endometrial cancer.

Being studied: Non-Interventional Study

Conditions: Endometrial Carcinoma

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Self-identified Black individuals ≥ 45 years with an intact uterus
  • Assigned female sex at birth
  • Experience with abnormal uterine or post-menopausal bleeding (defined as vaginal bleeding between periods, heavy vaginal bleeding, vaginal bleeding after menopause, and/or red, brown, or pink colored vaginal discharge after menopause)
  • Willing to participate in a 45-minute virtual interview

Exclusion Criteria

  • Previous or current diagnosis of endometrial cancer

Recruiting US locations

  • Mayo Clinic in Rochester

    Rochester, MN 55905

    Site contact: Clinical Trials Referral Office · 855-776-0015

Study contacts (from the official record)

  • Clinical Trials Referral Office · 855-776-0015 · mayocliniccancerstudies@mayo.edu
  • Kelly Gunderson · 507-422-1892
All healthy volunteers studies in Minnesota →
Acceptability of Testing DNA Markers in Vaginal Fluid for the… (NCT07527143) | Bored Studies